Literature DB >> 8110501

Incidence, survival and mortality in cervical cancer in Norway, 1956-1990.

T Bjørge1, S O Thoresen, G B Skare.   

Abstract

Long-term trends in incidence, survival and mortality were examined in women with squamous cell carcinoma and adenocarcinoma of the uterine cervix, diagnosed in Norway in the 35-year period 1956-1990. During the 1970s the number of cervical smears increased substantially in Norway, although no organised screening programme was introduced. Special attention was paid to the time period 1971-1990 to evaluate the effect of the extensive spontaneous screening. In addition, the prognostic importance of clinical stage and age was explored. In the squamous cell carcinoma patients the incidence rate peaked in the time period 1971-1975, since when there has been a decrease. In the adenocarcinoma patients the incidence rate rose through the years 1976-1990. Also, the proportion of adenocarcinomas increased in this time period. The mortality rates in both histological types declined modestly through the years 1966-1990. A more favourable stage distribution was noted among the squamous cell carcinomas (P = 0.00), but not among the adenocarcinomas, when comparing the two diagnostic periods 1971-1975 and 1981-1985. The multivariate analysis (GLIM) revealed that stage was the most important prognostic factor in both histological types (P = 0.00). In the squamous cell carcinoma patients the relative rate increased (P = 0.04) in the last period. There was a tendency towards a poorer prognosis in younger women in this group, but age did not prove to be an important prognostic factor (P = 0.08).

Entities:  

Mesh:

Year:  1993        PMID: 8110501     DOI: 10.1016/0959-8049(93)90224-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

2.  Mass screening for cervical cancer in Norway: evaluation of the pilot project.

Authors:  T Bjørge; A B Gunbjørud; O A Haugen; G B Skare; C Tropé; S O Thoresen
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

3.  HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing.

Authors:  Bjørn Inge Bertelsen; Kalaiarasy Kugarajh; Robert Skar; Ole Didrik Laerum
Journal:  Virchows Arch       Date:  2006-06-10       Impact factor: 4.064

4.  Reproductive factors and prognosis of uterine cervical cancer in Norway.

Authors:  T Bjørge; O Kravdal
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

5.  Reproductive variables and risk of uterine cervical cancer in Norwegian registry data.

Authors:  T Bjørge; O Kravdal
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

6.  Trends in cancer of the cervix uteri in Sweden following cytological screening.

Authors:  R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

7.  Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.

Authors:  Shalini L Kulasingam; Steve Benard; Ruanne V Barnabas; Nathalie Largeron; Evan R Myers
Journal:  Cost Eff Resour Alloc       Date:  2008-02-15

8.  Widowhood and divorce in relation to overall survival among middle-aged Norwegian women with cancer.

Authors:  A Kvikstad; L J Vatten; S Tretli
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.